Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of Ngo-B interacting proteins

ABSTRACT: Proteins interacting with Nogo-B were identified by CO-IP mass spectrometry

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Ke Gong

LAB HEAD: Ke Gong

PROVIDER: PXD046118 | Pride | 2024-07-29

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	checksum.txt	Txt
	raw.zip	Other
	result.zip	Other

Items per page:

1 - 3 of 3

Similar Datasets

The potential interacting proteins of QQS by IP-MS

Project description:To further examined the potential interacting proteins of QQS in pollen development, we performed IP-MS analysis using Arabidopsis anthers of the wild type, 35S:QQS-Flag and 35S:QQS-GFP lines at flower stage 12-15.

2024-07-20 | PXD038184 | Pride

Nogo-B co-IP-MS experiment in mouse liver and pancreas

Project description:Co-immunoprecipitation with either rabbit normal IgG or anti-Nogo-B antibody followed by mass spectrometry (co-IP-MS) in the liver and pancreas of wild-type C57BL/6J mice.

2024-07-27 | PXD046104 | Pride

Id2 and E proteins orchestrate the initiation and maintenance of MLL-rearranged acute myeloid leukemia

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-06-29 | E-GEOD-68463 | biostudies-arrayexpress

Transcription profiling of by comparing human breast cancer cell line MDA-MB-468 cyclin E transfected cells with control-transfected cells vs a control

Project description:We studied the effect of cyclin E overexpression in the breast cancer cell line MDA-MB-468, by comparing cyclin E transfected cells with control-transfected cells. The cyclin E/control hybridization was performed twice and cDNA from control transfected cells was used as a reference.

2005-05-31 | E-MEXP-339 | biostudies-arrayexpress

LMO2/LDB1 protein complex in AML cells

Project description:These are raw mass spectrometry data discussed in our paper: “The LMO2-LDB1-TAL1 complex regulates transcription networks in AML”, where we implicate this multisubunit complex as a key regulator of leukemia cell transcription. The key method was affinity purification followed by tandem mass spectrometry. The LDB1 and LMO2 proteins were FLAG tagged and encoding cDNAs were cloned into lentiviral expression vectors allowing transduction of leukemia cells. Protein purification and MS/MS are described below.

2026-02-09 | PXD068576 | Pride

Transcription profiling of human bladder cancer cell line TCCSUP over-expressing the transcription factor Oct-4 and control-tansfected cells

Project description:Comparison of TCCSUP cancer cells transformed with an EGFP control vector vs transcription factor Oct-4 overexpressed line of TCCSUP cancer cells

2008-09-30 | E-MEXP-1378 | biostudies-arrayexpress

Transcription profiling of human mesenchymal tumours cells over-expressing wild type vs truncated HMGA2 protein

Project description:The HMGA2 gene is frequently deranged by translocation and/or amplification in mesenchymal tumours, generally leading to over-expression of shorted transcripts and a truncated protein. In this experiment we have over-expressed wild type and truncated HMGA2 protein in an immortalized mesenchymal stem-like cell line and investigated their effects on gene expression patterns.

2010-06-26 | E-MEXP-2647 | biostudies-arrayexpress

CdGAP is a Talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis

Project description:Epithelial-to-mesenchymal transition (EMT) plays a crucial role in metastasis, which is the leading cause of death in breast cancer patients. We show that Cdc42 GTPase-activating protein (CdGAP) promotes tumor formation and metastasis to lungs in the HER2-positive (HER2+) murine breast cancer model. CdGAP facilitates intravasation, extravasation, and growth at metastatic sites. CdGAP depletion in HER2+ murine primary tumors mediates crosstalk with a Dlc1-RhoA pathway and is associated with a transforming growth factor-β (TGF-β)-induced EMT transcriptional signature. To further delineate the molecular mechanisms underlying the pro-migratory role of CdGAP in breast cancer cells, we searched for CdGAP interactors by performing a proteomic analysis using HEK293 cells overexpressing GFP-CdGAP. We found that CdGAP interacts with the adaptor Talin to modulate focal adhesion dynamics and integrin activation. Moreover, HER2+ breast cancer patients with high CdGAP mRNA expression combined with a high TGF-β-EMT signature are more likely to present lymph node invasion. Our results suggest CdGAP as a candidate therapeutic target for HER2+ metastatic breast cancer by inhibiting TGF-β and Integrin/Talin signaling pathways.

2023-07-14 | PXD043376 | Pride

Effect of Nogo deficiency on the insulin signaling pathway

Project description:The elevation of Nogo-B expression in T2DM mice and Nogo-B knockdown alleviated diabetic symptoms in db/db mice prompted us to further investigate the involvement of Nogo-B in the insulin signaling pathway and T2DM. The three isoforms of Nogo are derived from various RNA splicing events, so deleting Nogo-B exons 2-4 results in the deficiency of other Nogo members, resulting in Nogo knockout (Nogo-/-) mice. As the liver is the key organ in the systemic response to insulin and controls glucose and lipid metabolism, we conducted RNA-seq of livers isolated from 8-week-old Nogo-/- mice and WT littermates.

2023-07-24 | GSE236979 | GEO

RNA sequencing expression analysis of murine MLL-AF9;NRAS acute myeloid leukemia cells silenced for E2-2.

Project description:We investigated the role of the transcriptional regulators Id2 and E2-2 (encoded by Tcf4) in the context of MLL-rearranged acute myeloid leukemia (AML). Using an AML mouse model driven by a Tet-off inducible MLL-AF9 allele co-expressed with oncogenic NRASG12D, we demonstrated that MLL-AF9 regulates the E protein pathway by suppressing Id2, while activating the expression of its target E2-2. Moreover, we found that Id2 over-expression in MLL-AF9 AML cells results inhibition of leukemia growth, loss of leukemia stem cell-associated gene expression pattern and induction of differentiation. E2-2 silencing phenocopies Id2 overexpression in MLL-AF9-AML cells. To study the gene expression changes associated with E2-2 depletion in the context of MLL-rearranged AML, RNA sequencing analysis was performed on MLL-AF9;NRAS AML cells transduced with vectors expressing hairpins against E2-2 (shTcf4#654 and shTcf4#3646) or a control hairpin against Renilla luciferase (shRen). Primary AMLs driven by MLL/AF9 expression linked to cherry reporter, in association with oncogenic NRASG12D (MLL/AF9;NRAS) were generated by reconstituting lethally irradiated congenic mice with fetal liver cells co-transduced with the MSCV-MLL/AF9-IRES-cherry retroviral vector and a second vector co-expressing NRASG12D together with luciferase (MSCV-luciferase-IRES-NRASG12D). RNA sequencing analysis sequencing analysis was performed on MLL-AF9;NRAS AML cells transduced in vitro with vectors expressing hairpins against E2-2 (shTcf4#654 and shTcf4#3646) or a control hairpin against Renilla luciferase (shRen) linked to the reporter GFP. Viable GFP-positive cells were FACS-sorted 2 days after transduction and used for RNA sequencing analysis. Two independent biological replicates of the experiment were used for the RNA sequencing (9-5-14 and 14-4-14).

2016-06-29 | E-GEOD-80745 | biostudies-arrayexpress